Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Clinical and Molecular Risk-Directed Therapy For Newly Diagnosed Medulloblastoma
Protocol ID
SJMB12
Disease (Sub Disease)
Brain and Spinal Tumours (Medulloblastoma/PNET)
Diagnosis Stage
New diagnosis
Location
NSW, QLD, VIC, WA, NZ
Sponsor
St. Jude Children's Research Hospital
Collaborators
Genentech, Inc.
National Cancer Institute (NCI)
Trial Status
Open
Sites
The Children's Hospital at Westmead
Perth Children's Hospital
Queensland Children's Hospital
Royal Children's Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
3 Years to 39 Years
International registry ID's
NCT01878617
Back to Registry
Study Title A Clinical and Molecular Risk-Directed Therapy For Newly Diagnosed Medulloblastoma
Protocol ID SJMB12
Disease (Sub Disease) Brain and Spinal Tumours (Medulloblastoma/PNET)
Diagnosis Stage New diagnosis
Location NSW / QLD / VIC / WA / NZ
Sponsor St. Jude Children's Research Hospital
Collaborators Genentech, Inc./ National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT01878617
Trial Status Open
Trial Open Date 12/03/2014
Sites The Children's Hospital at Westmead / Perth Children's Hospital / Queensland Children's Hospital / Royal Children's Hospital / Starship Hospital
Study Type Treatment
Phase Phase 3
Age Eligibility 3 Years to 39 Years
International registry ID's NCT01878617